Upgrade to SI Premium - Free Trial

Benitec Biopharma (BNTC)

12.15 +0.35 (2.97%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/22/26 *Est.)

Latest Headlines

Guggenheim Downgrades Benitec BioPharma (BNTC) to Neutral June 10, 2026 6:47 AM - StreetInsider Form 8-K Benitec Biopharma Inc. For: May 22 May 29, 2026 4:11 PM - SEC Filing Form 4 Benitec Biopharma Inc. For: May 26 Filed by: Friedman David Matthew May 28, 2026 9:10 PM - SEC Filing Form 3 Benitec Biopharma Inc. For: May 22 Filed by: Friedman David Matthew May 28, 2026 9:09 PM - SEC Filing Benitec BioPharma (BNTC) Reiterated at Market Outperform by Citizens on Q3 Update May 18, 2026 7:20 AM - StreetInsider Benitec Biopharma (BNTC) Misses Q3 EPS by 24c May 14, 2026 8:35 AM - StreetInsider Form 10-Q Benitec Biopharma Inc. For: Mar 31 May 14, 2026 8:11 AM - SEC Filing Form 8-K Benitec Biopharma Inc. For: May 14 May 14, 2026 8:09 AM - SEC Filing Benitec Biopharma reports Q3 2026 results, advances BB-301 trial May 14, 2026 8:01 AM - StreetInsider Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update May 14, 2026 8:01 AM - Globe NewsWire Evercore ISI Starts Benitec BioPharma (BNTC) at Outperform May 12, 2026 8:22 AM - StreetInsider Benitec Biopharma to present BB-301 clinical data at gene therapy meeting April 28, 2026 7:00 AM - StreetInsider Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of April 28, 2026 7:00 AM - Globe NewsWire Seaport Therapeutics appoints Dr. Sharon Mates to board of directors April 27, 2026 7:05 AM - StreetInsider PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors April 27, 2026 7:05 AM - BizWire Seaport Therapeutics adds former Intra-Cellular CEO to board April 27, 2026 7:00 AM - StreetInsider Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors April 27, 2026 7:00 AM - BizWire Full Article List